Kamran Ahmed1, Shahid A Khan1, Matthew H Hayn2, Piyush K Agarwal3, Ketan K Badani4, M Derya Balbay5, Erik P Castle6, Prokar Dasgupta1, Reza Ghavamian7, Khurshid A Guru8, Ashok K Hemal9, Brent K Hollenbeck10, Adam S Kibel11, Mani Menon3, Alex Mottrie12, Kenneth Nepple11, John G Pattaras13, James O Peabody3, Vassilis Poulakis14, Raj S Pruthi15, Joan Palou Redorta16, Koon-Ho Rha17, Lee Richstone18, Matthias Saar19, Douglas S Scherr20, Stefan Siemer19, Michael Stoeckle19, Eric M Wallen15, Alon Z Weizer10, Peter Wiklund21, Timothy Wilson22, Michael Woods23, Muhammad Shamim Khan1. 1. MRC Centre for Transplantation, King's College London, Department of Urology, Guy's Hospital, London, UK. 2. Maine Medical Center, Division of Urology, Portland, ME, USA. 3. Henry Ford Health System, Detroit, MI, USA. 4. Columbia University Medical Center, New York, NY, USA. 5. Memorial Şişli Hospital, Istanbul, Turkey. 6. Mayo Clinic, Scottsdale, AZ, USA. 7. Montefiore Medical Center, UN Hospital Albert Einstein College of Medicine, Bronx, NY, USA. 8. Roswell Park Cancer Institute, Buffalo, NY, USA. Electronic address: khurshid.guru@roswellpark.org. 9. Wake Forest University Baptist Medical Center, Salem, NC, USA. 10. University of Michigan Health System, Ann Arbor, MI, USA. 11. Washington University School of Medicine, St. Louis, MO, USA. 12. Onze-Lieve-Vrouw Ziekenhuis, Aalst, Belgium. 13. Emory University School of Medicine, Atlanta, GA, USA. 14. Doctor's Hospital of Athens, Athens, Greece. 15. University of North Carolina, NC, USA. 16. Fundacio Puigvert, Barcelona, Spain. 17. Yonsei University Health Systems Severance Hospital, Seoul, Korea. 18. Arthur Smith Institute for Urology, New Hyde Park, NY, USA. 19. University Clinics of Saarland, Homburg, Germany. 20. Weill Cornell Medical College, New York, NY, USA. 21. Karolinska University Hospital, Stockholm, Sweden. 22. City of Hope and Beckman Research Institute, Duarte, CA, USA. 23. Loyola University Medical Center, Maywood, IL, USA.
Abstract
BACKGROUND: Intracorporeal urinary diversion (ICUD) has the potential benefits of a smaller incision, reduced pain, decreased bowel exposure, and reduced risk of fluid imbalance. OBJECTIVE: To compare the perioperative outcomes of patients undergoing extracorporeal urinary diversion (ECUD) and ICUD following robot-assisted radical cystectomy (RARC). DESIGN, SETTING, AND PARTICIPANTS: We reviewed the database of the International Robotic Cystectomy Consortium (IRCC) (18 international centers), with 935 patients who had undergone RARC and pelvic lymph node dissection (PLND) between 2003 and 2011. INTERVENTION: All patients within the IRCC underwent RARC and PLND as indicated. The urinary diversion was performed either intracorporeally or extracorporeally. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Demographic data, perioperative outcomes, and complications in patients undergoing ICUD or ECUD were compared. All patients had at least a 90-d follow-up. The Fisher exact test was used to summarize categorical variables and the Wilcoxon rank sum test or Kruskal-Wallis test for continuous variables. RESULTS AND LIMITATIONS: Of 935 patients who had RARC and PLND, 167 patients underwent ICUD (ileal conduit: 106; neobladder: 61), and 768 patients had an ECUD (ileal conduit: 570; neobladder: 198). Postoperative complications data were available for 817 patients, with a minimum follow-up of 90 d. There was no difference in age, gender, body mass index, American Society of Anesthesiologists grade, or rate of prior abdominal surgery between the groups. The operative time was equivalent (414 min), with the median hospital stay being marginally longer for the ICUD group (9 d vs 8 d, p=0.086). No difference in the reoperation rates at 30 d was noted between the groups. The 90-d complication rate was not significant between the two groups, but a trend favoring ICUD over ECUD was noted (41% vs 49%, p=0.05). Gastrointestinal complications were significantly lower in the ICUD group (p ≤ 0.001). Patients with ICUD were at a lower risk of experiencing a postoperative complication at 90 d (32%) (odds ratio: 0.68; 95% confidence interval, 0.50-0.94; p=0.02). Being a retrospective study was the main limitation. CONCLUSIONS: Robot-assisted ICUD can be accomplished safely, with comparable outcomes to open urinary diversion. In this cohort, patients undergoing ICUD had a relatively lower risk of complications.
BACKGROUND: Intracorporeal urinary diversion (ICUD) has the potential benefits of a smaller incision, reduced pain, decreased bowel exposure, and reduced risk of fluid imbalance. OBJECTIVE: To compare the perioperative outcomes of patients undergoing extracorporeal urinary diversion (ECUD) and ICUD following robot-assisted radical cystectomy (RARC). DESIGN, SETTING, AND PARTICIPANTS: We reviewed the database of the International Robotic Cystectomy Consortium (IRCC) (18 international centers), with 935 patients who had undergone RARC and pelvic lymph node dissection (PLND) between 2003 and 2011. INTERVENTION: All patients within the IRCC underwent RARC and PLND as indicated. The urinary diversion was performed either intracorporeally or extracorporeally. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Demographic data, perioperative outcomes, and complications in patients undergoing ICUD or ECUD were compared. All patients had at least a 90-d follow-up. The Fisher exact test was used to summarize categorical variables and the Wilcoxon rank sum test or Kruskal-Wallis test for continuous variables. RESULTS AND LIMITATIONS: Of 935 patients who had RARC and PLND, 167 patients underwent ICUD (ileal conduit: 106; neobladder: 61), and 768 patients had an ECUD (ileal conduit: 570; neobladder: 198). Postoperative complications data were available for 817 patients, with a minimum follow-up of 90 d. There was no difference in age, gender, body mass index, American Society of Anesthesiologists grade, or rate of prior abdominal surgery between the groups. The operative time was equivalent (414 min), with the median hospital stay being marginally longer for the ICUD group (9 d vs 8 d, p=0.086). No difference in the reoperation rates at 30 d was noted between the groups. The 90-d complication rate was not significant between the two groups, but a trend favoring ICUD over ECUD was noted (41% vs 49%, p=0.05). Gastrointestinal complications were significantly lower in the ICUD group (p ≤ 0.001). Patients with ICUD were at a lower risk of experiencing a postoperative complication at 90 d (32%) (odds ratio: 0.68; 95% confidence interval, 0.50-0.94; p=0.02). Being a retrospective study was the main limitation. CONCLUSIONS: Robot-assisted ICUD can be accomplished safely, with comparable outcomes to open urinary diversion. In this cohort, patients undergoing ICUD had a relatively lower risk of complications.
Authors: J W Collins; A Hosseini; P Sooriakumaran; T Nyberg; R Sanchez-Salas; C Adding; Martin C Schumacher; N P Wiklund Journal: Curr Urol Rep Date: 2014-11 Impact factor: 3.092
Authors: Keiran D Clement; Emily Pearce; Ahmed H Gabr; Bhavan P Rai; Abdulla Al-Ansari; Omar M Aboumarzouk Journal: World J Urol Date: 2020-07-30 Impact factor: 4.226